Shire Cited for Marketing of Its ADHD Drug Intuniv FDA news (subscription) ... Advertising and Communications over direct-to-consumer promotions for its attention-deficit hyperactivity disorder (ADHD) drug Intuniv. ...

Merck announced that the Committee for Medicinal Products for Human Use adopted a positive opinion on the pending Marketing Authorization Application for SYCREST (asenapine) sublingual tablets. The CHMP has recommended that the European Commission grant a marketing authorization for SYCREST for the treatment of moderate to severe manic episodes associated with bipolar I disorder in adults. The ...

Howard Dean to Speak at the 2010 DTC National Conference PharmaLive (press release) (subscription) Additional keynote speakers scheduled to appear at the 2010 conference include Tom Curatolo, Product Director, Vyvanse Marketing, Shire US, Inc.; ...